Bioengineering, Volume 12, Issue 2
2025 February - 116 articles
Cover Story: Critical-sized bone defects, which can result from trauma, infection, or tumor removal, present major challenges for orthopedic surgeons. Current treatments like bone grafts have significant limitations such as donor site complications and variable outcomes. Regional gene therapy has emerged as a promising solution that combines genetic engineering with tissue engineering principles. This approach involves either directly delivering therapeutic genes to the defect site or implanting genetically modified stem cells that produce bone-forming proteins. Such stem cells can be obtained from various sources including bone marrow, fat, or muscle tissue. This strategy aims to provide all the essential components for bone repair while minimizing the complications associated with the current treatments. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.